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Optimization of RT-qPCR protocols to quantify chuA gene expression in
Campylobacter jejuni mutants under iron-limited conditions
Jacob Wilbert
Dr. Jeremiah Johnson M.S. Ph.D.
Department of Microbiology
University of Tennessee, Knoxville

ABSTRACT
Campylobacter jejuni is the most prevalent cause of bacterial derived cases of
gastroenteritis worldwide. Additionally, due to its severe symptoms and increasing antibiotic
resistance, it is posing a serious threat to public health in most societies. C. jejuni warrants
investigation in order to better understand the systems and mechanisms it utilizes to successfully
infect humans and cause disease. The chu gene cluster is comprised of five genes employed in the
uptake and utilization of heme as an iron source. These genes are regulated by two transcriptional
regulators, Fur and HeuR, in an iron-dependent manner. Further investigation must be performed
to fully understand how these two regulators work in tandem to regulate the chu system under
differing iron conditions. Accordingly, this study reviews and refines the multifaceted protocols
used prior to the quantitative analysis of chuA gene expression via Reverse TranscriptaseQuantitative Polymerase Chain Reaction (RT-qPCR). The topics addressed include bacterial
growth conditions, RNA extraction, RNA purification, and primer optimization. The main
implication of these optimized and refined protocols is a more efficacious approach to RT-qPCRs
in future studies.
Keywords: Campylobacter, Fur, HeuR, chu, RT-qPCR

BACKGROUND
Campylobacter jejuni is a motile, gram-negative bacteria and a worldwide threat to public
health due to its severity of symptoms and rising antibiotic resistance [9]. Ninety-six million cases
of diarrheal disease reported globally in 2010 were attributed to Campylobacter species with an
estimated 1.3 million cases each year in the United States [9]. Of all of the bacterial causes of
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gastroenteritis, Campylobacter jejuni is the most common in the United States (~45%), ahead of
both Salmonella (~30%) and E. coli O157 (~5%) [1]. Common symptoms include fever,
abdominal cramping, and bloody diarrhea while infants, elders, and people with underlying health
problems are at increased risk for the more severe symptoms such as sepsis, Guillain-Barré
syndrome, and death [1].
Iron is a cofactor for many enzymes in processes such as the electron transport chain, which
makes it a vital nutrient for bacterial infection [2]. C. jejuni cannot survive without iron, so it must
have the ability to obtain it from the environment or its host organism. However, limitation of free
iron is a common means of host nutritional immunity, so C. jejuni and most other pathogenic
bacterial species have evolved various methods of iron acquisition [2]. They have developed the
particular specialty of obtaining iron from the ubiquitous cofactor heme, as heme is the most
abundant source of iron in humans. Because iron acquisition is critical, bacterial mechanisms of
utilizing heme, and most iron sources, are very well refined and controlled [2]. Heme utilization
is especially efficacious in tandem with the presence of blood in stool during campylobacteriosis.
One of these iron acquisition systems present in C. jejuni is the chu system. This is a system
of five proteins that act in conjunction to uptake and utilize heme as an iron source [8]. The chuA
gene encodes an extracellular heme receptor, chuB and chuC encode a permease and ATP binding
domain, respectively, of a hemin ABC transporter, chuD encodes a hemin binding protein in the
periplasm, and chuZ encodes a heme oxygenase that frees iron from heme [8]. ChuZ utilizes the
same promoter region as chuABCD, but it is divergently transcribed [8]. Our unpublished data also
shows the chuABCD system is transcribed as an operon, so chuA regulation should be
representative of the system (Supplementary Figure S1).
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In the presence of iron, the transcription of chuZABCD is repressed by the ferric uptake
regulator (Fur) protein. Iron is an activating cofactor of the transcriptional regulator Fur, so as
intracellular iron concentration increases, Fur is more active and binds to the promotor region of
iron uptake genes, repressing transcription. The transcriptome of a C. jejuni 11168 wild type (WT)
and Δfur strain under iron-replete and iron-limited conditions was captured using RNAseq [5].
This revealed that, when compared to a WT strain under iron-replete conditions, the chu system is
downregulated in WT under iron-limited conditions and upregulated in a Δfur strain in iron-replete
conditions. Additionally, under iron-limited conditions, there is no significant change in chuA
expression between a WT strain and a Δfur strain [5].
Another transcriptional regulator, denoted HeuR (heme uptake regulator), has been shown
to positively regulate the chu system, along with many other genes in C. jejuni 81-176. This
regulatory mechanism is less well understood than Fur regulation, so further investigation must be
done to understand HeuR regulation of the chu system [8]. It is known that HeuR also binds the
chuZA promoter region and that each of the chuABCD genes is regulated similarly with the chuZ
gene being less, but still significantly, affected. The same study also showed that with heme as the
sole iron source both heuR and chuA mutant strains were significantly less viable when compared
to the wild type strain with heme as an iron source [8]. Another study shows that chuA and chuD
were very highly upregulated, >500 fold and >100 fold respectively, during human infection [6].
This fact suggests that the system is heavily utilized and may be necessary for C. jejuni to colonize
the human gut. With increasing antibiotic resistance, finding novel treatments for
campylobacteriosis warrants attention. If the chu genes are required for colonization, then they or
other heme acquisition systems could potentially be targets for novel treatments.
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Although the chu genes are shown to be downregulated both in a WT strain under ironlimited conditions and in a heuR mutant under iron-replete conditions, their differential expression
has not yet been quantified in a heuR mutant under iron-limited conditions. Additionally, as Fur
and HeuR both regulate the chu system at the same promoter, a study of differential expression
needs to be performed in a fur + heuR double mutant strain to investigate the amount of chu
expression without either of these transcriptional regulators [5],[8]. Because chuABCD is
transcribed as an operon, the expression of the system can be tentatively represented by chuA
expression in Reverse Transcriptase Quantitative Polymerase Chain Reaction (RT-qPCR)
(Supplementary Figure S1).
RT-qPCR is a method of quantifying gene expression based on the number of RNA
transcripts present at a given time [14]. RNA is extracted from a sample and cDNA is synthesized
from the RNA using reverse transcriptase. This cDNA is used as the starting template DNA in
quantitative PCR with primers specific for a gene of interest and one or multiple internal control
genes [14]. The qPCR mixture contains molecules that fluoresce when DNA is in a certain state,
such as double stranded, that are read by the thermocycler every cycle. Every time the DNA
replicates, each strand fluoresces, so as more DNA is synthesized fluorescence increases. The
number of cycles that it takes to exceed a given amount of fluorescence is termed the Threshold
Cycle (CT) [14].
The choice of internal control gene is vital to quantifying differential expression. Ideally,
the best internal control genes will have no change in expression across many conditions,
especially the experimental condition [13]. Sometimes referred to as “housekeeping genes” the
best internal controls are very highly conserved between organisms and vital to survival. The
expression of genes that encode proteins like RNA polymerases is rarely changed because the cell
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is so reliant on their functionality, which is why they make perfect controls [13]. Because the
expression of this gene does not change, the expression of the target gene can be quantified as
expression is normalized to the internal controls. It is best to use more than one internal control to
account for any possible failure to maintain unchanged expression in any one of the internal
controls. This ensures that the change in the target gene’s expression is being calculated accurately
[13].
The differential expression of the target gene is calculated by determining the change in C T
values between the control and experimental conditions relative to the change in expression in the
internal control between the conditions. This comparison can be performed using the 2−ΔΔCT
method, which was originally described by Livak and Schmittgen. This method will return the
differential CT values as fold changes relative to the controls [10].

PURPOSE
The aim of this study is to refine the protocols that precede the quantification of expression
of the target gene through RT-qPCR in C. jejuni 81-176. Although the differential expression of
the target gene chuA under conditions of interest will not be quantified in this study, I seek to
establish the most consistent and effective protocols so that all subsequent studies aiming to use
RT-qPCR are as efficient as possible. The immediate applications of this study will allow for the
quantification of chuA expression in wild-type, heuR mutant, Δfur, and Δfur + heuR::kan double
mutant strains in iron-limited conditions through the use of RT-qPCR. These protocols specific to
C. jejuni may then be utilized for other genes and conditions of interest in future studies.

5

BACTERIAL STRAINS AND GROWTH CONDITIONS
The strains of Campylobacter jejuni used in this study were 81-176 wild type, heuR::kan,
Δfur, and Δfur + heuR::kan double mutant, with all mutants in a 81-176 background. Our
heuR::kan mutant was created by inserting a kanamycin resistance cassette into the heuR gene to
ultimately result in a nonfunctional protein, while the Δfur mutant was a clean deletion. These four
strains were routinely cultured on Mueller-Hinton (MH) agar supplemented with trimethoprim as
a selection factor for C. jejuni, kanamycin when appropriate, and 5% sheep’s blood for
supplemental nutrients. All incubation periods were consistent at 37°C under microaerophilic
conditions (85% N2, 10 % CO2, & 5% O2).
In this study, control conditions are arbitrarily defined by the standard concentrations and
species of iron contained in Mueller-Hinton (MH) broth. We have previously shown that
deferoxamine mesylate (DFOM) at a total concentration of 1.5mM is effective at sequestering
usable iron in liquid media and significantly reducing growth of C. jejuni. So, I define iron-limited
conditions (the experimental condition) in this study as MH Broth with DFOM added to a final
concentration of 1.5mM.
Cultures of each strain were inoculated on agar two days prior to the start of the experiment
and grown overnight. Fresh lawns of each strain were spread on new agar using a disposable loop
and grown overnight again. Cells were gathered using disposable loops and suspended in MH
broth. Three sterile 250mL flasks were prepared with 100mL of sterile MH broth for each strain
and each experimental condition (24 total). Each suspended strain was used to inoculate three
flasks with standard iron concentrations and three flasks with limited iron concentrations to an
initial OD600 of 0.1.
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In order to determine how long to grow the liquid cultures so that the RNA is captured midlog in the growth phase, the absorbance at 600nm wavelength was measured each hour from hour
0 through hour 12, again at hour 16, then every 8 hours until 48 hours. The growth curves for the
four strains in each condition are shown in Figure 1. It was determined from these growth curves
that the bacterial growth is mid-log at approximately 6 hours (OD600 = 0.2-0.25), so that is when
the cultures will be captured for RNA extraction in future experiments.
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Figure 1 – Growth curves of 81-176 wild type, heuR::kan, Δfur, and Δfur + heuR::kan double mutant in a) standard
and b) limited iron conditions. Time points were taken on the hour at time 0 through 12 hours, again after 4 hours,
then every 8 hours until 48 hours. Time points were captured using absorbance at 600nm wavelength.
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RNA EXTRACTION
The process to extract RNA must be done with extreme caution as to not contaminate the
samples with RNases. RNases are present on nearly every surface, as they are able to travel through
air and are found plentifully in dust and on human skin [11]. Additionally, just as surfaces can be
contaminated with RNases, all of the solutions and reagents used in this process can become
contaminated easily. Consequently, it is critical that the following protocols are performed with
fresh, nuclease-free reagents and equipment in a clean, ventilated hood. Nuclease-free disposable
equipment such as filtered pipette tips will be designated as such, and non-disposable equipment
such as pipettes and work surfaces should be cleaned with commercial RNase inhibitors prior to
use.
RNA was extracted via phenol-chloroform extraction using RiboZol™ from VWR™. The
extraction procedure was performed as follows:
1.
2.
3.
4.

Centrifuge the cell suspension to form a pellet and remove supernatant.
Resuspend the pellet in 500µL of RiboZol™.
Incubate for 5 minutes at room temperature to allow for complete lysis of cells.
Add 500µL of chloroform and vortex to mix. Incubate 2-3 minutes at room
temperature. Chloroform should be handled in a chemical hood to avoid inhalation of
vapors.
5. Centrifuge at 13,000 rpm for 15 minutes at 4°C.
6. Transfer clear aqueous phase to a new labeled microcentrifuge tube.
7. (Optional) Add 1µL of glycogen coprecipitant to help visualize RNA pellet.
8. Add 50µL of 7.5M Ammonium Acetate and 500µL of 100% Ethanol to each tube and
incubate at -20°C for 2 hours.
9. Centrifuge at 12,000 x g for 15 minutes at 4°C.
10. Remove the supernatant and wash the pellet with 150µL of 70% ethanol.
11. Remove the supernatant and allow pellets and tubes to airdry for 20 minutes or until
dry.
12. Resuspend the pellet in 25µL nuclease-free water and incubate samples for 10 minutes
at 55-60°C to help dissolve the RNA pellet.
13. RNA can be used immediately or stored at -80°C.
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Once the RNA is obtained, it must be analyzed to make sure it is usable. Firstly, the
integrity of the samples should be assessed to confirm the absence of RNases. Then, the yield of
RNA must be measured to ensure that there is enough sample RNA to use in downstream
protocols. Lastly, the purity of the samples tested to detect any contaminants in the sample that
may pose problems in subsequent reactions. The RNA samples obtained with this protocol had
some contaminants, but they had decent yields (50-250ng/µL) and were considered intact. The
following discussion will explain methods of analysis, how to remove contaminants from the
samples, and ways to improve this protocol to prevent contamination.
There are multiple methods to analyze the integrity of the RNA extracted. The method that
was used for this experiment was an agarose gel with added bleach to visualize total RNA. Intact
RNA will appear as two bands in an agarose gel with the top band being approximately twice the
intensity of the bottom band. The top band represents the large subunit rRNA, and the bottom band
represents the small subunit rRNA. The bleach in the gel acts to inhibit any RNases that would
otherwise be found in the gel that may degrade the RNA [3]. Alternatively, formaldehyde can be
used to treat the gel, but this is more costly and requires more safety concerns. To make a bleach
gel, the normal 1% agarose mixture is heated until the agarose is completely dissolved before pure
bleach is added 1% v/v (1 mL beach into 99mL mixture) to the hot agarose mixture. The bleach
can be added before the mixture is heated, but the bleach may vaporize and could cause harm to
the user as it is being heated. Once the bleach is added and the mixture has cooled down, it can be
poured into a mold with the addition of EtBr, and the gel can be used normally [3]. The integrity
of the RNA samples extracted in this experiment are shown in Figure 2. There are two bands in all
but one of the lanes with the top band being more intense than the bottom band, suggesting that
the RNA in those samples is intact. The RNA samples in the lanes that do not show the same
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banding patterns are likely to have been exposed to an RNase and the sample is degraded.
Alternatively, the sample might not have had a high enough concentration of RNA to fluoresce
visibly.

Figure 2 – An image of RNA visualized by ethidium bromide in an agarose gel. In each of the first 12 lane on top and
bottom, the top band shows the large subunit rRNA and the bottom band shows the small subunit rRNA. The RNA
samples were loaded into the lanes as follows from left to right in triplicate: wild type, heuR mutant, Δfur, Δfur +
heuR double mutant. Samples in the top lanes were from standard iron conditions, and the samples on the bottom lanes
were from iron-limited conditions. DNA ladders were added in the rightmost visible lanes on top and bottom, and a
positive gDNA control was added to the left of the ladder on the bottom.

The RNA samples can be analyzed by spectrophotometry to find the yield and purity. The
yield that is given, however, is not always reliable for two reasons. Firstly, all nucleic acids absorb
at 260nm, so if there is any DNA contamination or free nucleotides then the concentration reading
will be skewed. Secondly, if there is leftover phenolic and guanidine isothiocyanate reagents from
the RNA extraction, they can absorb at and around 260nm and cause the concentration reading to
be inaccurate [7]. A low yield can be increased by increasing the amount of cell suspension that is
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pelleted, but the amount of RiboZol™ and other reagents should be increased incrementally as
more cell suspension is used. To determine RNA purity, the 260/280 and 260/230 ratios must be
determined. A pure RNA sample will have a 260/280 ratio of ~2.0 and a 260/230 ratio of ~2.02.2. If these ratios are lower than these expected values, then that means the RNA sample is not
pure. Common contaminants can be phenol, proteins, and carbohydrates such as a glycogen
coprecipitant [7]. The samples obtained in this experiment yielded concentrations between
approximately 50 and 200 ng/µL and contained contaminants. Most of the 260/230 ratios were
near or below 1.0 and the 260/280 ratios were near 1.5, indicating multiple species of
contaminants.
It is important that these contaminants are not present in the RNA samples so that they do
not disturb any downstream treatments such as the reverse transcription and qPCR. There are
different ways to purify RNA samples, but some are more efficacious than others in that some
methods result in a loss of RNA quantity. Using a commercial RNA cleanup kit is the easiest and
quickest method to clean an RNA sample, but it can also result in a loss of RNA. Performing an
additional phenol-chloroform extraction would remove protein and DNA contamination while
sparing RNA quantity, but it could potentially introduce further phenol contamination if care is
not taken. Ultimately, preserving a usable RNA concentration is of utmost concern, and after many
trials of both methods, I have found that the best way to remove contaminants and preserve the
RNA is to repeat phenol chloroform extractions. It is crucial to take great care and deliberation
with every step as to not further contaminate the sample. It also seems that the most influential
step in preventing contamination is the ethanol wash step. The RNA extraction protocol described
previously utilized inadequate wash steps and, as a result, yielded highly contaminated samples.
To increase the effectiveness of the ethanol wash steps, it should be performed with 1mL of 70%
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ethanol and should be repeated at least once until all contaminants are removed. The added volume
and steps will allow for greater solvation and removal of salt, protein, carbohydrate, phenol, and
other contaminants, but with every time the wash step is performed, there is risk for losing RNA.
If this protocol is adequately effective, then the initial phenol-chloroform extraction should be able
to produce pure RNA with good yield and there should be no need for additional phenolchloroform extractions. The revised protocol with additional wash steps is as follows:
1.
2.
3.
4.

Centrifuge the cell suspension to form a pellet and remove the supernatant.
Resuspend the pellet in 500µL of RiboZol™.
Incubate for 5 minutes at room temperature to allow for complete lysis of cells.
Add 500µL of chloroform and vortex to mix. Incubate 2-3 minutes at room
temperature. Chloroform should be handled in a chemical hood to avoid inhalation of
vapors.
5. Centrifuge at 13,000 rpm for 15 minutes at 4°C.
6. Transfer clear aqueous phase to a new labeled microcentrifuge tube.
7. (Optional) Add 1µL of glycogen coprecipitant to help visualize RNA pellet.
8. Add 50µL of 7.5M Ammonium Acetate and 500µL of 100% Ethanol to each tube and
incubate at -20°C for 2 hours.
9. Centrifuge at 12,000 x g for 15 minutes at 4°C.
10. Remove the supernatant and wash the pellet with 1mL of 70% ethanol.
11. Repeat wash step at least once to ensure thorough removal of contaminants.
12. Remove the supernatant and allow pellets and tubes to airdry for 20 minutes or until
dry.
13. Resuspend the pellet in 25µL nuclease-free water and incubate samples for 10 minutes
at 55-60°C to help dissolve the RNA pellet.
14. RNA can be used immediately or stored at -80°C.

RNA PURIFICATION
It is critical that there is no detectable genomic DNA contamination in an RNA sample if
it is to be used in RT-qPCR. When RNA is reverse transcribed, the amount of cDNA generated
reflects the proportion of target mRNA transcripts and, in turn, the amount that the gene of interest
was expressed. If there is existing gDNA in the sample, then the primers intended to bind and
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amplify the cDNA will bind the gDNA and amplify it as well. This will result in an uncontrolled
overestimation of target gene expression. To test whether there is gDNA contamination in the
sample, a standard PCR can be run with the sample and a primer set for a positive control gene,
mapA in this case, and the product can be analyzed via gel electrophoresis. The PCR should be run
for 40 cycles, the same as qPCR, because the difference in DNA amplification between 30 and 40
cycles is one thousand-fold, so this will reveal absolutely any gDNA that would also be revealed
in qPCR. The RNA samples I obtained were tested for gDNA in the following way:








25µL total reaction volume
 12.5µL Thermo Fisher DreamTaq DNA polymerase
 9.5µL nuclease-free water
 1µL [10mM] mapA forward primer
 1µL [10mM] mapA reverse primer
 1µL RNA sample
95°C initial denature for 3 minutes
95°C denature for 30 seconds, x40 cycles
45°C annealing stage for 30 seconds, x40 cycles
65°C elongation stage for 1 minute, x40 cycles
65°C final elongation for 7 minutes

The PCR products obtained from this reaction were analyzed via gel electrophoresis on a
1% agarose gel. The PCR revealed that there was significant gDNA contamination in all 24 RNA
samples, as shown in Figure 3. The presence of these bands indicates that there is preexisting
template DNA in the RNA samples and that our positive control gene, mapA, was able to amplify.
Our primers for mapA generate an amplicon that is 500 base pairs in size. If these samples were
used in qPCR as they are, all of this gDNA would amplify on top of the target cDNA and cause
the CT values to be inaccurate.

Figure 3 – An image of genomic DNA contamination in RNA samples prior to any DNase treatments. Genomic DNA
was amplified by PCR and visualized by ethidium bromide on an agarose gel. The visible band represents the positive
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control gene mapA. RNA samples are arranged as follows from left to right in triplicates: wild type with standard iron,
heuR::kan mutant with standard iron, Δfur with standard iron, Δfur + heuR::kan double mutant with standard iron,
wild type with limited iron, heuR::kan mutant with limited iron, Δfur with limited iron, and Δfur + heuR::kan double
mutant with limited iron.

To remove contaminating genomic DNA from these RNA samples, a DNase treatment
must be performed. The DNase is from an Ambion® DNase I kit. The manufacturer’s
recommendation for use of this product is adding the DNase buffer (10X) to a concentration of 1X
in the RNA sample, adding 1µL of DNase enzyme (2U), and incubating the reaction at 37°C for
30 minutes. This reaction should digest up to 2µg of DNA, but after four subsequent iterations of
this reaction on the same samples, there was still genomic DNA contamination. There is not an
inherent problem with having to do multiple DNase treatments; however, after every treatment a
step is required to either inactivate or remove the DNase enzyme from the reaction. There are a
few manufacturer-recommended methods of inactivating or removing the DNase, but each poses
its own challenges.
The first method is by phenol chloroform extraction, which may introduce a number of
contaminants back into the sample or lose RNA during any one of the steps. Another method is by
heat inactivation. The manufacturer recommends adding EDTA to 5mM and heating to 75°C for
10 minutes to inactivate the DNase. The problem with this method is that EDTA is a magnesium
chelator. If too much EDTA accumulates from subsequent reactions it will inhibit downstream
PCRs because magnesium is essential for enzyme function. Additionally, if more than one DNase
treatment is needed, then any extra EDTA might inactivate any new DNase. A third manufacturerrecommended method is through gel purification where samples may be run through an agarose
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gel to separate the components of the reaction, but this method results in the loss of RNA through
the gel extraction. A final method, one that was not mentioned by the manufacturer, is to run the
reaction mixture through an RNA cleanup kit. Some of these kits are designed to do DNase
treatments in-column, so they are effective at removing the reaction components and returning
only the RNA. The only challenge with these is that they often lose RNA quantity. The challenge
presented here is to minimize the number of times the sample has to be treated because the more
times it has to be treated, the more times it has to be cleaned, meaning the DNase treatment must
be optimized to work at maximum capacity.
The DNase treatment was optimized by manipulating the amounts of enzyme and the buffer
concentration. According to the product description, Ambion® DNase I is most effective when the
concentration of magnesium is 5mM, yet when the buffer is added to a final 1X concentration,
magnesium is only at a concentration of 2.5mM. So, the treatment at 1X buffer concentration was
compared to a treatment at 2X buffer concentration. Additionally, increasing the amount of
enzyme in the reaction should increase its capacity, so the amount of enzyme was manipulated in
conjunction with both buffer conditions. In total, there were four reaction combinations: 1X buffer
and 1µL enzyme, 2X buffer and 1µL enzyme, 1X buffer and 2µL enzyme, and 2X buffer and 2µL
enzyme. All four of these reactions received 1µL of the same untreated RNA sample and nucleasefree water up to a total volume of 20µL, and they were all treated simultaneously in the same
heating block at 37°C for 30 minutes. A Zymo Research RNA Clean & Concentrator™ kit was
used to clean the reactions and then the product was amplified using PCR as described above.
Figure 4 shows the results of these four reactions. All of the treatments were successful in
removing gDNA, but the reaction with the doubled enzyme amount and 2X buffer concentration
was clearly the most effective. There is still some gDNA contamination visible, but in this small
16

amount it would not noticeably affect a qPCR. Regardless, more optimization was performed to
ensure there is absolutely no traceable amount of gDNA.

Figure 4 – An image of DNase treatments after being cleaned with a Zymo Research RNA Clean & Concentrator ™
kit and remaining gDNA amplified by a 40 cycle PCR. The reactions are ordered in the lanes from left to right as
follows: 1) 1X buffer and 1µL enzyme, 2) 2X buffer and 1µL enzyme, 3) 1X buffer and 2µL enzyme, 4) 2X buffer
and 2µL enzyme, 5) a sample of the same untreated RNA that went into each of the DNase treatments, and 6) a
gDNA positive control.

To simulate performing two DNase treatments while only having to clean one time, the
reactions were spiked with additional amounts of reagents. In total, there were three different
reactions. All three started with 2µL of enzyme, 2X buffer concentration (4µL), 1µL untreated
RNA sample, and nuclease-free water up to 20µL and were treated for 30 minutes at 37°C.
Subsequently, they were all spiked with an extra 2µL of enzyme, one was also spiked with 4µL of
buffer, the second was also spiked with 2µL of buffer, and the third did not receive extra buffer.
They were treated again for 30 minutes at 37°C, then cleaned and amplified as previously
described. Figure 5 shows the results of this optimization. The reaction that was spiked with 2µL
of DNase and an additional 4µL of buffer performed the best and was capable of digesting all
traces of gDNA. This method effectively performs two DNase treatments with the most effective
combination of reagents while only having to clean the reaction once. This allows for the complete
removal of contaminating gDNA while preserving as much RNA in the sample as possible.
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Figure 5 – An image of DNase treatments after being spiked with varying additional reagents. In the lanes from left
to right: 1) a DNA ladder, 2) a DNase treatment that was spiked only with 2µL of DNase, 3) a DNase treatment that
was spiked with 2µL of DNase and 2µL of buffer, 4) a DNase treatment that was spiked with 2µL of DNase and 4µL
of buffer, 5) the untreated RNA that went into each reaction, and 6) a gDNA positive control.

Once all of the contaminating gDNA is removed from the samples, the RNA should be tested
again for integrity. This can be done using commercial methods like an Agilent Technologies, Inc.
Bioanalyzer kit or with a bleach gel [3]. Using the commercial method is preferred, as it is more
accurate and detailed. After the quality of the RNA is established as intact, then it is ready to be
used for RT-qPCR.

RT-qPCR PRIMER DESIGN AND OPTIMIZATION
New qPCR primers were designed for the chuA gene using NCBI Primer BLAST® and
analyzed and synthesized by Integrated DNA Technologies™. I obtained primer sequences for an
internal control, rpoA, from a publication by Ritz et al. which were also analyzed and synthesized
by Integrated DNA Technologies™ [13]. The primer set for chuA was designed to be as similar to
rpoA as possible to allow for maximum efficiency from both primers when used together under
the same parameters. The properties of the primers are shown in Table 1.
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Table 1 – A listing of qPCR primers used in this study and their properties.

Primer

Nucleotide sequence (5’-3’)

Tm (°C)

%GC

chuA forward

ACC AGC AGT GGC TAT CTA AC

61.4

50

chuA reverse

CAG GGC GAT TGA TTT GTG TG

61.4

50

rpoA forward

CGA GCT TGC TTT GAT GAG TG

61.3

50

rpoA reverse

AGT TCC CAC AGG AAA ACC TA

60.9

45

Several tests of optimization must be conducted to ensure the primer sets perform at their
optimal efficiency. The ideal efficiency (100% amplification) of a qPCR reaction is when the
amount of template DNA increases two-fold with each reaction cycle [4]. If a primer set is
inefficient then not all of the DNA will be replicated in any single reaction which will result in an
underestimation of the amount of initial template DNA. Several factors that can lead to inefficient
primers are annealing temperatures being too high, primer concentrations being too low, or primer
GC content being too low. If a primer set results in greater than 100% amplification, that is
indicative of nonspecific binding or primer secondary structures. The polymerase mixture used in
these reactions is iTaq™ Universal SYBR™ Green Supermix from Bio-Rad Laboratories, Inc.
Because SYBR™ Green fluoresces when DNA is double stranded, primer dimers, secondary
primer structures such as hairpins, and primers binding nonspecifically to DNA all will fluoresce
and be measured as replicated DNA. These occasions will result in an overestimation of the amount
of initial template DNA.
In order to find the best annealing/elongation temperature parameter to use in the
experimental qPCR, the primers must first be tested at many different temperatures. I performed a
sample qPCR with a gradient of annealing/elongation temperatures and the following parameters
in duplicate for both primer sets:

19








20µL reaction volume
 10 µL iTaq™ Universal SYBR™ Green Supermix
 7 µL nuclease free water
 1 µL forward primer (10µM stock; 500nM final concentration)
 1 µL reverse primer (10µM stock; 500nM final concentration)
 1 µL gDNA at 10ng/µL concentration
95°C Initial denature, 3 minutes
95°C denature, 30 seconds, x40 cycles
Annealing/elongation temperature within 56-64°C, 1 minute, x40 cycles
Duplicate reactions for each primer set, for each of the 8 gradient temperatures for a
total of 32 reactions.

The quality of each primer set can be assessed first by calculating the range of the C T values
measured from the range of temperatures. A well-designed primer will have little change in C T
value over a range of temperatures, indicating a binding affinity that is independent from
temperature conditions [4]. This is important when working with multiple primer sets as it is
possible that each one will have different optimal conditions. If one primer set anneals best at 55°C
and another at 65°C, then your reaction will be less than optimal for one or both of the primer sets.
However, if one or both primer sets are able to anneal with high efficiency over a wide range of
temperatures, then having to use a temperature that accounts for different primer sets does not
become problematic. The optimal annealing temperature for each primer in this test was
determined by finding the lowest CT value, which indicates the highest amount of amplification.
As Table 2 depicts, there is high variability in the range and average of C T values of the
technical replicates of each primer set. Despite this variability between replicates the different
primer sets are still comparable, which may indicate that the variability is due to systematic error
in the reaction setup. Both primer sets were able to produce an appreciably low range in C T values
and had comparable average CT values, meaning that these primer sets are relatively independent
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of changing annealing temperatures and amplify DNA at similar efficiencies. When taking both
replicates into account and regardless of error, it seems the optimal annealing/elongation
temperature to use for these primer sets is approximately 62°C.

Table 2 – Threshold cycle (CT) values for chuA and rpoA primer sets for a range of annealing/elongation
temperatures. Bolded values mark the lowest CT value for each replicate range of temperatures.

Annealing/Elongation
Temperature

chuA

rpoA

64°C

15.56

18.77

15.04

18.51

63.6°C

15.33

17.07

14.73

19.02

62.7°C

14.84

15.81

14.83

15.39

61.1°C

15.12

16.85

15.20

16.06

59.2°C

14.47

27.86

15.17

35.01

57.6°C

14.66

22.18

15.53

35.15

56.5°C

16.02

21.70

15.15

32.46

56°C

16.74

36.62

16.29

N/A

Average

15.34

22.11

15.24

24.51

Range

2.27

20.81

1.56

19.76

Another parameter of a qPCR that must be optimized is the concentration of primers used
in each reaction. The optimal primer concentration will vary based on the properties of the primers
themselves. Primers that have a weaker binding affinity to their gene might need a higher
concentration to maintain the optimum efficiency of replication. If there is not enough primer or
the primer is too weak, then the reaction could be inefficient. To optimize the concentrations of
each primer, all other parameters were held constant as they were in the temperature gradient test,
except for temperature which was held at 62°C. Primer concentration was increased stepwise from
200nM to 500nM in duplicate reactions of each primer pair. Results from this test are shown in
Table 3.
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Assuming that a lower CT value represents a higher reaction efficiency, there was no
considerable difference in reaction efficiency between primer concentrations of 300nM and
500nM. The reactions for rpoA at 400nM primer concentration yielded no results, which was likely
due to an error in the reaction setup that resulted in each replicate missing a reaction component.
However, because of the lack of change in efficiency between these values, it is also likely that
400nM would have similar efficiency. Additional experimentation would be needed to show that,
and further reactions will not be based on a primer concentration of 400nM because of this lack of
confirmation. Based on this test and preexisting standard practices, further experiments will be
conducted with a primer concentration of 500nM.

Table 3 – Threshold cycle (CT) values for chuA and rpoA primer sets at various primer concentrations. Bolded values
mark the lowest CT value for each replicate range of primer concentrations.

Primer Concentration (nM)

chuA

rpoA

200

12.13

11.88

12.18

11.91

300

11.73

11.68

11.55

11.69

400

11.86

11.65

N/A

N/A

500

11.74

11.9

11.64

11.49

After these tests of optimization are complete, the primer efficiencies must be tested. This
can be done by making reactions with serial dilutions of template DNA, typically ten-fold, and
plotting their CT values against the number of dilutions to create a standard curve [4]. If a primer
set is 100% efficient, the CT values will increase as the amount of starting template DNA decreases
with a negative slope. The slope corresponds with the number of cycles that it takes to amplify the
same amount of template DNA that is changed by each dilution. So, if the reactions have ten-fold
changes in starting template, then you would expect to see a slope of -3.322 because it takes 3.322
cycles to generate a ten-fold increase in DNA at 100% efficiency [4]. However, if the CT values
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change with a lesser or greater magnitude of slope, that indicates that the primers are over or under
100% efficient, respectively. For example, if your primers are 150% efficient then you would
expect a lower slope because it takes less cycles to achieve ten-fold amplification. Likewise, if
your efficiency is 50%, then you would expect a higher slope because it takes more cycles to
achieve the same ten-fold change in DNA. Assuming 100% efficiency, the relationship between
the dilution factor, D, and the number of cycles, n, it takes to amplify that amount of DNA is shown
below as (1). You can find the theoretical slope by solving for n, which is shown below by (2) [4].

D = 2n

(1)

n = log (𝐷)

(2)

To find the actual efficiency of the primer set, you much plot each C T value against its fold
change and find the slope of the line. Efficiency (E) can then be calculated with (3) and percent
efficiency (%E) can be calculated with (4).

E=𝐷

/

%E = (E-1) * 100%

(3)
(4)

The obtained CT values and efficiencies for the chuA and rpoA primer sets are displayed in
Table 4, and the CT values are plotted in Figure 6. In this case, a dilution factor of 5 was used
across 4 reactions in duplicate for each primer set, meaning the first reaction had a set amount of
template, then each subsequent reaction had 5 times less template than the previous.
Based on the standard curve, both the chuA and rpoA primer sets work beyond maximum
efficiency. This suggests that there is some extraneous double stranded binding, whether that is
primer dimers, primer secondary structures, or nonspecific primer binding. After analyzing the
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melt curve of both primer sets, there is only one peak very consistently at 75-76°C which implies
that there is no significant alternative double stranded DNA formation. It is possible that the higher
efficiency is due to errors in preparing the reactions. Ideally, these primers should be redesigned
to be closer to 100% efficiency. However, these primers could be used, and the qPCR results could
be analyzed with the Pfaffl method, which accounts for different reaction efficiencies, instead of
the 2−ΔΔCT method [12].

Table 4 – Threshold cycle (CT) values of chuA and rpoA at varying fold changes of starting template DNA. Efficiency
(E) and percent efficiency (%E) were calculated from the slopes of each replicate.

Starting Template
DNA (ng)

chuA

rpoA

2

15.35

15.52

15.08

15.18

10

13.21

13.08

12.85

12.96

50

11.35

11.1

11.12

11.08

250

10.2

9.73

9.8

9.69

Slope

-1.731

-1.935

-1.757

-1.835

E

2.53

2.3

2.5

2.4

%E

153%

130%

150%

140%
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Figure 6 – Standard curves of a) chuA and b) rpoA primer sets. Duplicate reactions are overlaid on each graph. The
equation of each replicate is labelled in standard slope-intercept form. Starting template DNA refers to the initial
amount of DNA added to each reaction, and each step is a five-fold increase in the amount.
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IMPLICATIONS AND CONCLUSIONS
The aim of this study was to refine the protocols that precede the quantification of
expression of the target gene through RT-qPCR in C. jejuni 81-176. If the methods developed and
refined here are successful, these preparations can be used to attain pure, intact RNA and to
optimize primer sets. Once pure, intact RNA is obtained and the primer sets are optimized, the
next step is to generate cDNA and to quantify the target gene. Because, pure RNA from this
experiment has yet to be obtained, this step has not been optimized. Further experimentation with
this reaction is necessary to determine the amounts of reagent to add and reaction times. It is
probable that, similar to the DNase treatments, adding more enzyme and buffer will increase the
effectiveness of the reaction. Additionally, testing longer reaction times might yield better results.
If Fur and HeuR control the chu system how we expect, then we would expect to see
increased expression of chuA in the fur mutant and decreased expression in the heuR mutant when
compared to the WT strain in similar conditions. As iron is an activating cofactor of Fur, we would
expect to see higher chuA expression in general under iron-limited conditions compared to
standard iron conditions. Physiologically, this makes sense because as the presence of iron
decreases in the cell, heme uptake should increase to replenish the intracellular iron concentration.
However, it is difficult to speculate specific levels of expression in confounding conditions, such
as a mutant strain under iron-limited conditions. The level of expression is difficult to attribute to
any one of these factors under iron-limited conditions without actually performing the experiment
and comparing it to its corresponding control.
Further, as both of these regulators use the same promoter for the chu genes, this
investigation might provide insight into how they interact with each other. In the Δfur + heuR::kan
double mutant, neither transcriptional regulator is present. So, unless there is another regulator
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acting on this promoter, the basal rate of expression should be detected in both the presence and
absence of iron. I propose that without these regulators there is no sensory mechanism to regulate
expression of the chu genes, so similar levels of expression should be observed with and without
iron. When looking at this basal rate in comparison to the level of expression in a single mutant
strain and wild type in both conditions, it could reveal how the presence or absence of either
regulator affects the other. For example, the repressor is absent in a Δfur strain, so expression
increases. Not only is the repressor absent, but the activator is now able to bind to the promoter
because there is no longer binding competition for the promoter. This aspect of chu control needs
further investigation to determine the mechanisms of competition between Fur and HeuR
regulation.
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PRODUCTS AND SERVICES REFERENED
RiboZol™ by VWR™
https://us.vwr.com/store/product/7437721/vwr-life-science-ribozoltm-rna-extraction-reagent
Ambion® nuclease-free Dnase I
https://www.thermofisher.com/order/catalog/product/AM2224#/AM2224
RNA Clean & Concentrator™ by Zymo Research
https://www.zymoresearch.com/collections/rna-clean-concentrator-kits-rcc/products/rna-cleanconcentrator-5
Bioanalyzer RNA kit by Agilent Technologies, Inc.
https://www.agilent.com/en/product/automated-electrophoresis/bioanalyzer-systems/bioanalyzerrna-kits-reagents
National Center for Biotechnology Information (NCBI) Primer-BLAST®
https://www.ncbi.nlm.nih.gov/tools/primer-blast/
qPCR primers synthesized by Integrated DNA Technologies™
https://www.idtdna.com/pages
iTaq™ Universal SYBR™ Green Supermix by Bio-Rad Laboratories, Inc.
https://www.bio-rad.com/en-us/product/itaq-universal-sybr-green-supermix?ID=M87FTF8UU
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SUPPLEMENTARY FIGURES
Figure S1 – An image of intergenic sequences showing amplicons that indicate shared transcription between the
chuABCD genes. From left to right: a 1 kilobase DNA ladder, cDNA of chuAB intergenic region, RNA of chuAB
intergenic region prior to reverse transcription, cDNA of chuBC intergenic region, RNA of chuBC intergenic region
prior to reverse transcription, cDNA of chuCD intergenic region, RNA of chuCD intergenic region prior to reverse
transcription.
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